Title : ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma.

Pub. Date : 2016 Jul

PMID : 27089170






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma. Lenalidomide DNA damage inducible transcript 3 Homo sapiens
2 In Phase II studies, lenalidomide combined with R-CHOP (R(2)-CHOP) improved outcomes relative to historical R-CHOP in newly diagnosed DLBCL, particularly in non-GCB cases. Lenalidomide DNA damage inducible transcript 3 Homo sapiens
3 In Phase II studies, lenalidomide combined with R-CHOP (R(2)-CHOP) improved outcomes relative to historical R-CHOP in newly diagnosed DLBCL, particularly in non-GCB cases. Lenalidomide DNA damage inducible transcript 3 Homo sapiens